Leo and Art have both indicated that the whole B platform will preferably be partnered with one entity. It would be difficult for two or more BP to be advertising Brilacidin for different indications at the same time. They have stated P would probably be first
(2)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links